Citadel Advisors
PRAX icon

Citadel Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Citadel Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
+7,331
New +$2.32M ﹤0.01% 6106
2026
Q1 		– Sell
-34,917
Closed -$10.8M – 13959
2025
Q4 		$10.3M Buy
34,917
+27,119
+348% +$5.05M ﹤0.01% 3220
2025
Q3 		$413K Sell
7,798
-2,568
-25% -$125K ﹤0.01% 9586
2025
Q2 		$436K Sell
10,366
-51,844
-83% -$1.97M ﹤0.01% 8951
2025
Q1 		$2.36M Sell
62,210
-30,980
-33% -$1.93M ﹤0.01% 5223
2024
Q4 		$7.17M Buy
93,190
+45,156
+94% +$3.27M ﹤0.01% 3409
2024
Q3 		$2.76M Buy
48,034
+25,388
+112% +$1.37M ﹤0.01% 4942
2024
Q2 		$937K Sell
22,646
-3,362
-13% -$159K ﹤0.01% 6715
2024
Q1 		$1.59M Sell
26,008
-30,471
-54% -$1.37M ﹤0.01% 5977
2023
Q4 		$1.26M Buy
56,479
+15,243
+37% +$275K ﹤0.01% 6240
2023
Q3 		$1.06M Sell
41,236
-2,711
-6% -$51.3K ﹤0.01% 6451
2023
Q2 		$758K Buy
43,947
+2,361
+6% +$36.1K ﹤0.01% 7037
2023
Q1 		$505K Sell
41,586
-8,769
-17% -$370K ﹤0.01% 8290
2022
Q4 		$1.8M Sell
50,355
-21,718
-30% -$677K ﹤0.01% 5674
2022
Q3 		$2.45M Sell
72,073
-23,907
-25% -$1.19M ﹤0.01% 5192
2022
Q2 		$3.53M Sell
95,980
-7,374
-7% -$787K ﹤0.01% 4461
2022
Q1 		$15.8M Sell
103,354
-4,881
-5% -$1M ﹤0.01% 2285
2021
Q4 		$32M Sell
108,235
-1,014
-0.9% -$297K 0.01% 1545
2021
Q3 		$30.3M Sell
109,249
-14,679
-12% -$3.98M 0.01% 1555
2021
Q2 		$34M Buy
123,928
+17,069
+16% +$6.11M 0.01% 1487
2021
Q1 		$52.5M Buy
106,859
+483
+0.5% +$343K 0.01% 1005
2020
Q4 		$87.8M Buy
+106,376
New +$62.1M 0.02% 621

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Citadel Advisors's PRAX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 7,331 shares worth $2.45M. The stake represents ﹤0.01% of the portfolio and ranks #6106 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PRAX as recently as Q4 2025.

Citadel Advisors first reported a position in PRAX in Q4 2020 and has held it in 22 quarters since. The position peaked at $87.8M in Q4 2020. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Citadel Advisors held 7,331 shares of Praxis Precision Medicines worth $2.45M as of Q2 2026.
  • Praxis Precision Medicines was a new Citadel Advisors position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6106 holding.
  • Citadel Advisors first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 22 quarters since.
  • Citadel Advisors's Praxis Precision Medicines position peaked at $87.8M in Q4 2020.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.